| Hint | Answer | % Correct |
|---|---|---|
| NSAID | ibuprofen | 57%
|
| penicillin | amoxicillin | 43%
|
| opioid anti-motility agent | weak opioid | codeine | 43%
|
| strong opioid | morphine | 43%
|
| weak analgesic | paracetamol | 43%
|
| antiplatelet drug | aspirin | 29%
|
| beta blocker | class 2 antiarrhythmics - beta blocker | bisoprolol | 29%
|
| benzodiazepine | diazepam | 29%
|
| SSRIs | fluoxetine | 29%
|
| loop diuretics | furosemide | 29%
|
| opioid addiction management | methadone | 29%
|
| proton pump inhibitor | omeprazole | 29%
|
| anticoags - factor Xa inhibitor | rivaroxaban | 29%
|
| SSRIs | sertraline | 29%
|
| anticoags - coumarin | warfarin | 29%
|
| calcium channel blocker | amlodipine | 14%
|
| anticoags - factor Xa inhibitor | apixaban | 14%
|
| HMG-CoA reductase inhibitor | atorvastatin | 14%
|
| ARB | candesartan | 14%
|
| ACE inhibitors | captopril | 14%
|
| antihistamine | cetirizine | 14%
|
| fluoroquinolones | ciprofloxacin | 14%
|
| SSRIs | citalopram | 14%
|
| penicillin | co-amoxiclav | 14%
|
| vitamin D supplement | Colecalciferol | 14%
|
| anticoags - heparin | dalteparin | 14%
|
| NSAID | diclofenac | 14%
|
| calcium channel blocker | class 4 antiarrhythmics - Ca channel blocker | diltiazem | 14%
|
| anticoags - heparin | enoxaparin | 14%
|
| penicillin | flucloxacillin | 14%
|
| neuropathic pain drug | gabapentin | 14%
|
| thiazide | hydrochlorothiazide | 14%
|
| corticosteroid IV | glucocorticoid | hydrocortisone | 14%
|
| long acting insulin | insulin glargine | 14%
|
| proton pump inhibitor | lansoprazole | 14%
|
| class 1b antiarrhythmics - Na channel blocker | lidocaine | 14%
|
| ARB | losartan | 14%
|
| labour supplement | magnesium | 14%
|
| carbapenem | meropenem | 14%
|
| class 2 antiarrhythmics - beta blocker | metoprolol | 14%
|
| benzodiazepine | midazolam | 14%
|
| opioid antagonist | naloxone | 14%
|
| NSAID | naproxen | 14%
|
| nitrofuran | nitrofurantoin | 14%
|
| labour augmentation | oxytocin | 14%
|
| corticosteroid oral | glucocorticoid | prednisolone | 14%
|
| neuropathic pain drug | pregabalin | 14%
|
| class 2 antiarrhythmics - beta blocker | propranolol | 14%
|
| ACE inhibitors | ramipril | 14%
|
| antineoplastic monoclonal antibody | rituximab | 14%
|
| HMG-CoA reductase inhibitor | simvastatin | 14%
|
| methylxanthine | theophylline | 14%
|
| antineoplastic monoclonal antibody | trastuzumab | 14%
|
| calcium channel blocker | class 4 antiarrhythmics - Ca channel blocker | verapamil | 14%
|
| nucleoside reverse transcriptase inhibitor (NRTI) | abacavir | 0%
|
| DNA polymerase inhibitor | acyclovir | 0%
|
| cytokine modulator | adalimumab | 0%
|
| adenosine | adenosine | 0%
|
| sympathomimetics | adrenaline | 0%
|
| bisphosphonate | alendronate | 0%
|
| thrombolytics/fibrinolytics | alteplase | 0%
|
| antacids | aluminium and magnesium hydroxide/calcium carbonate | 0%
|
| potassium sparing diuretic | amiloride | 0%
|
| methylxanthine | aminophylline | 0%
|
| class 3 antiarrhythmics - K channel blocker | amiodarone | 0%
|
| neuropathic pain drug | amitriptyline | 0%
|
| faecal softener | arachis oil | 0%
|
| beta blocker | class 2 antiarrhythmics - beta blocker | atenolol | 0%
|
| antimuscarinic | atropine | 0%
|
| antimetabolite immunosuppressant | azathioprine | 0%
|
| macrolide | azithromycin | 0%
|
| corticosteroid inhaled | beclomethasone | 0%
|
| thiazide | bendroflumethiazide | 0%
|
| dopa-decarboxylase inhibitor | benserazide | 0%
|
| integrase inhibitor | bicetegravir | 0%
|
| stimulant laxative | bisacodyl | 0%
|
| mixed agonist opioid | opioid addiction management | buprenorphine | 0%
|
| therapeutic hormones for bone | calcitonin | 0%
|
| vitamin D supplement | calcitriol 1,25-dihydroxyvitamin D | 0%
|
| anti-epilepsy drug | carbemazepine | 0%
|
| dopa-decarboxylase inhibitor | carbidopa | 0%
|
| cephalosporin | ceftriaxone | 0%
|
| COX2 selective NSAID | celecoxib | 0%
|
| antihistamine | chlorphenamine | 0%
|
| thiazide | chlorthalidone | 0%
|
| h2-receptor antagonist | cimetidine | 0%
|
| antiplatelet drug | clopidogrel | 0%
|
| anticoags - thrombin inhibitor | dabigatran | 0%
|
| monoclonal antibody | denosumab | 0%
|
| progesterone only contraceptive | desogestrel | 0%
|
| combination pill contraceptive | desogestrel and ethinylestradiol | 0%
|
| glucocorticoid | dexamethasone | 0%
|
| strong opioid | diamorphine | 0%
|
| cardiac glycosides | digoxin | 0%
|
| weak opioid | dihydrocodeine | 0%
|
| labour induction | dinoprostone | 0%
|
| class 1A antiarrhythmics - Na channel blocker | disopyramide | 0%
|
| sympathomimetics | dobutamine | 0%
|
| faecal softener | docusate | 0%
|
| integrase inhibitor | dolutegravir | 0%
|
| cholinesterase inhibitor | donepezil | 0%
|
| alpha blocker | doxazosin | 0%
|
| tetracycline | doxycycline | 0%
|
| class 3 antiarrhythmics - K channel blocker | dronedarone | 0%
|
| anticoags - factor Xa inhibitor | edoxaban | 0%
|
| nucleoside reverse transcriptase inhibitor (NRTI) | emtricitabine | 0%
|
| COMT inhibitor | entacapone | 0%
|
| potassium sparing diuretic | epleronone | 0%
|
| macrolide | erythromycin | 0%
|
| HRT | estradiol | 0%
|
| cytokine modulator | etanercept | 0%
|
| anti-TB drugs (concurrent) | ethambutol | 0%
|
| implant/injectable contraceptive | etonogestrel | 0%
|
| COX2 selective NSAID | etoricoxib | 0%
|
| h2-receptor antagonist | famotidine | 0%
|
| class 1c antiarrhythmics - Na channel blocker | flecainide | 0%
|
| corticosteroid oral/nasal | fluticasone | 0%
|
| essential pregnancy supplement - neural tube | folic acid | 0%
|
| beta 2 adrenergic agonist | formoterol | 0%
|
| cholinesterase inhibitor | galantamine | 0%
|
| DNA polymerase inhibitor | ganciclovir | 0%
|
| aminoglycoside | gentamycin | 0%
|
| nitrates | glyceryl trinitrate | 0%
|
| luteinising hormone releasing hormone receptor agonist | goserelin | 0%
|
| thiazide | indapamide, | 0%
|
| cytokine modulator | infliximab | 0%
|
| short acting insulin | insulin lispro | 0%
|
| therapeutic cytokines | interferon alpha | 0%
|
| antimuscarinic | ipratropium | 0%
|
| anti-TB drugs (concurrent) | isoniazid | 0%
|
| medium acting insulin | isophane insulin | 0%
|
| nitrates | isosorbide mononitrate | 0%
|
| bulk laxative | isphagula husk | 0%
|
| I(f) channel blocker | ivabradine | 0%
|
| hypocalcaemia | IV calcium gluconate | 0%
|
| magnesium | IV magnesium sulfate | 0%
|
| osmotic laxative | lactulose | 0%
|
| nucleoside reverse transcriptase inhibitor (NRTI) | lamivudine | 0%
|
| anti-epilepsy drug | lamotrigine | 0%
|
| immunomodulator | lenolidamide | 0%
|
| dopaminergic - precursor | levodopa | 0%
|
| progesterone only contraceptive | levonorgestrel | 0%
|
| thyroid hormones T4 | levothyroxine sodium | 0%
|
| thyroid hormones T3 | liothyronine sodium | 0%
|
| ACE inhibitors | lisinopril | 0%
|
| opioid anti-motility agent | loperamide | 0%
|
| benzodiazepine | lorazepam | 0%
|
| osmotic laxative | macrogol | 0%
|
| osmotic laxative | magnesium hydroxide | 0%
|
| osmotic laxative | magnesium sulphate | 0%
|
| HRT | medroxyprogesterone | 0%
|
| NMDA receptor antagonist | memantine | 0%
|
| aminosalicylate | mesalazine | 0%
|
| antifolaxe antiproliferative | methotrexate | 0%
|
| bulk laxative | methylcellulose | 0%
|
| nitroimidazole | metronizadole | 0%
|
| reversible inhibitor of monoamine oxidase type A | moclobemide | 0%
|
| leukotriene antagonist | montelukast | 0%
|
| calcium channel blocker | nifedipine | 0%
|
| antineoplastic monoclonal antibody | nivolumab | 0%
|
| sympathomimetics | noradrenaline | 0%
|
| HRT | noresthisterone | 0%
|
| anticholinergic | orphenadrine | 0%
|
| neuraminidase inhibitors | oseltamivir | 0%
|
| urinary antispasmodic | oxybutynin | 0%
|
| parathyroid hormone | pamidronate | 0%
|
| pancreatic enzymes | pancreatin | 0%
|
| hypocalcaemia | parathyroid hormone | 0%
|
| ACE inhibitors | perindopril | 0%
|
| synthetic opioid for labour | pethidine | 0%
|
| alpha blocker | phenoxybenzamine | 0%
|
| penicillin | phenoxymethylpenicillin | 0%
|
| penicillin | piperacillin-tazobactam | 0%
|
| dopaminergic - synthetic agonist | pramipexole | 0%
|
| anticholinergic | procyclidine | 0%
|
| class 1c antiarrhythmics - Na channel blocker | propafenone | 0%
|
| beta blocker | propranalol | 0%
|
| anti-TB drugs (concurrent) | pyrazinamide | 0%
|
| class 1A antiarrhythmics - Na channel blocker | quinidine | 0%
|
| selective estrogen receptor modulator for osteoporosis | raloxifene | 0%
|
| monoamine oxidase B inhibitor | rasagiline | 0%
|
| synthetic opioid for labour | remifentanil | 0%
|
| nucleoside analogues | ribavirin | 0%
|
| anti-TB drugs (concurrent) | rifampicin | 0%
|
| cholinesterase inhibitor | rivastigmine | 0%
|
| dopaminergic - synthetic agonist | ropinirole | 0%
|
| dopaminergic - synthetic agonist | rotigotine | 0%
|
| neprilysin inhibitors | sacubitril | 0%
|
| beta 2 adrenergic agonist | salbutamol | 0%
|
| beta 2 adrenergic agonist | salmeterol | 0%
|
| monoamine oxidase B inhibitor | selegiline | 0%
|
| stimulant laxative | senna | 0%
|
| antacid and alginates | sodium alginate with sodium bicarbonate | 0%
|
| anti-epilepsy drug | sodium valproate | 0%
|
| class 3 antiarrhythmics - K channel blocker | sotalol | 0%
|
| potassium sparing diuretic | spironolactone | 0%
|
| thrombolytics/fibrinolytics | streptokinase | 0%
|
| aminosalicylate | sulfasalazine | 0%
|
| selective oestrogen receptor modulator | tamoxifen | 0%
|
| alpha 1 blocker for altered voiding | tamsulosin | 0%
|
| nucleoside reverse transcriptase inhibitor (NRTI) | tenofovir | 0%
|
| beta 2 adrenergic agonist | terbutaline | 0%
|
| antiplatelet drug | ticagrelor | 0%
|
| anticoags - heparin | tinzaparin | 0%
|
| antimuscarinic | tiotropium | 0%
|
| COMT inhibitor | tolcapone | 0%
|
| potassium sparing diuretic | triamterene | 0%
|
| anticholinergic | trihexphenidyl | 0%
|
| antifolate | trimethoprim | 0%
|
| selective progesterone receptor modulator - emergency contraceptive | ulipristal | 0%
|
| anticoags - heparin | unfractionated heparins | 0%
|
| thrombolytics/fibrinolytics | urokinase | 0%
|
| ARB | valsartan | 0%
|
| glycopeptide | vancomycin | 0%
|
| essential pregnancy supplement - bone | hypocalcaemia | vitamin D | 0%
|
| leukotriene antagonist | zafirlukast | 0%
|